Deruxtecan
Product Description
Chongqing Sintaho Pharmaceutical Co., Ltd.
-
CN -
2023On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
Chongqing Sintaho Pharmaceutical Co., Ltd.
-
CN
-
2023On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Chongqing Sintaho Pharmaceutical Co., Ltd. (4)
-
Product Eribulin Mesylate
Eribulin (E7389) mesylate is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. -
Product Exatecan Mesylate
Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research. -
Product MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH
MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). -
Product Paclitaxel
Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance